UniProt ID | PRS7_HUMAN | |
---|---|---|
UniProt AC | P35998 | |
Protein Name | 26S proteasome regulatory subunit 7 | |
Gene Name | PSMC2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 433 | |
Subcellular Localization | Cytoplasm . Colocalizes with TRIM5 in cytoplasmic bodies. | |
Protein Description | Component of the 26S proteasome, a multiprotein complex involved in the ATP-dependent degradation of ubiquitinated proteins. This complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. Therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or DNA damage repair. PSMC2 belongs to the heterohexameric ring of AAA (ATPases associated with diverse cellular activities) proteins that unfolds ubiquitinated target proteins that are concurrently translocated into a proteolytic chamber and degraded into peptides.. | |
Protein Sequence | MPDYLGADQRKTKEDEKDDKPIRALDEGDIALLKTYGQSTYSRQIKQVEDDIQQLLKKINELTGIKESDTGLAPPALWDLAADKQTLQSEQPLQVARCTKIINADSEDPKYIINVKQFAKFVVDLSDQVAPTDIEEGMRVGVDRNKYQIHIPLPPKIDPTVTMMQVEEKPDVTYSDVGGCKEQIEKLREVVETPLLHPERFVNLGIEPPKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGSELVQKYVGEGARMVRELFEMARTKKACLIFFDEIDAIGGARFDDGAGGDNEVQRTMLELINQLDGFDPRGNIKVLMATNRPDTLDPALMRPGRLDRKIEFSLPDLEGRTHIFKIHARSMSVERDIRFELLARLCPNSTGAEIRSVCTEAGMFAIRARRKIATEKDFLEAVNKVIKSYAKFSATPRYMTYN | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Nitration | ----MPDYLGADQRK ----CCCCCCCCCCC | 10.93 | - | |
4 | Phosphorylation | ----MPDYLGADQRK ----CCCCCCCCCCC | 10.93 | 19664994 | |
9 | Ubiquitination | PDYLGADQRKTKEDE CCCCCCCCCCCCCCC | 48.51 | - | |
11 | Ubiquitination | YLGADQRKTKEDEKD CCCCCCCCCCCCCCC | 59.31 | 21906983 | |
13 | Ubiquitination | GADQRKTKEDEKDDK CCCCCCCCCCCCCCC | 67.23 | 21906983 | |
17 | Ubiquitination | RKTKEDEKDDKPIRA CCCCCCCCCCCCCCC | 81.30 | 21906983 | |
20 | Ubiquitination | KEDEKDDKPIRALDE CCCCCCCCCCCCCCH | 53.10 | 21906983 | |
34 | Ubiquitination | EGDIALLKTYGQSTY HHCEEEEEHHCCCHH | 40.32 | 21890473 | |
34 | Ubiquitination | EGDIALLKTYGQSTY HHCEEEEEHHCCCHH | 40.32 | 21890473 | |
34 | Acetylation | EGDIALLKTYGQSTY HHCEEEEEHHCCCHH | 40.32 | 23236377 | |
34 | Ubiquitination | EGDIALLKTYGQSTY HHCEEEEEHHCCCHH | 40.32 | 21906983 | |
34 | Ubiquitination | EGDIALLKTYGQSTY HHCEEEEEHHCCCHH | 40.32 | 21890473 | |
35 | Phosphorylation | GDIALLKTYGQSTYS HCEEEEEHHCCCHHH | 32.62 | 28152594 | |
36 | Phosphorylation | DIALLKTYGQSTYSR CEEEEEHHCCCHHHH | 16.16 | 28152594 | |
39 | Phosphorylation | LLKTYGQSTYSRQIK EEEHHCCCHHHHHHH | 25.58 | 29496907 | |
44 | Ubiquitination | GQSTYSRQIKQVEDD CCCHHHHHHHHHHHH | 41.09 | - | |
46 | Ubiquitination | STYSRQIKQVEDDIQ CHHHHHHHHHHHHHH | 39.70 | 21890473 | |
46 | Ubiquitination | STYSRQIKQVEDDIQ CHHHHHHHHHHHHHH | 39.70 | 21890473 | |
46 | Ubiquitination | STYSRQIKQVEDDIQ CHHHHHHHHHHHHHH | 39.70 | 21906983 | |
46 | Ubiquitination | STYSRQIKQVEDDIQ CHHHHHHHHHHHHHH | 39.70 | 21890473 | |
49 | Ubiquitination | SRQIKQVEDDIQQLL HHHHHHHHHHHHHHH | 47.69 | - | |
57 | Ubiquitination | DDIQQLLKKINELTG HHHHHHHHHHHHHHC | 61.27 | 21890473 | |
57 | Ubiquitination | DDIQQLLKKINELTG HHHHHHHHHHHHHHC | 61.27 | 21890473 | |
57 | Ubiquitination | DDIQQLLKKINELTG HHHHHHHHHHHHHHC | 61.27 | 21906983 | |
57 | Ubiquitination | DDIQQLLKKINELTG HHHHHHHHHHHHHHC | 61.27 | 21890473 | |
58 | Malonylation | DIQQLLKKINELTGI HHHHHHHHHHHHHCC | 51.22 | 26320211 | |
58 | Ubiquitination | DIQQLLKKINELTGI HHHHHHHHHHHHHCC | 51.22 | 21906983 | |
63 | Phosphorylation | LKKINELTGIKESDT HHHHHHHHCCCHHCC | 30.59 | 20068231 | |
66 | Ubiquitination | INELTGIKESDTGLA HHHHHCCCHHCCCCC | 53.13 | 21906983 | |
73 | Ubiquitination | KESDTGLAPPALWDL CHHCCCCCCHHHHHH | 14.91 | - | |
84 | Ubiquitination | LWDLAADKQTLQSEQ HHHHHHCHHCCCCCC | 40.22 | 21890473 | |
84 | Ubiquitination | LWDLAADKQTLQSEQ HHHHHHCHHCCCCCC | 40.22 | 21890473 | |
84 | Ubiquitination | LWDLAADKQTLQSEQ HHHHHHCHHCCCCCC | 40.22 | 21906983 | |
84 | Ubiquitination | LWDLAADKQTLQSEQ HHHHHHCHHCCCCCC | 40.22 | 21890473 | |
85 | Ubiquitination | WDLAADKQTLQSEQP HHHHHCHHCCCCCCC | 48.25 | - | |
100 | Acetylation | LQVARCTKIINADSE HHHHEEEEEEECCCC | 45.26 | 26051181 | |
100 | Ubiquitination | LQVARCTKIINADSE HHHHEEEEEEECCCC | 45.26 | 21906983 | |
106 | Phosphorylation | TKIINADSEDPKYII EEEEECCCCCCCEEE | 41.30 | 29214152 | |
110 | Ubiquitination | NADSEDPKYIINVKQ ECCCCCCCEEEEHHH | 62.49 | 21890473 | |
110 | Ubiquitination | NADSEDPKYIINVKQ ECCCCCCCEEEEHHH | 62.49 | 21890473 | |
110 | Acetylation | NADSEDPKYIINVKQ ECCCCCCCEEEEHHH | 62.49 | 27452117 | |
110 | Ubiquitination | NADSEDPKYIINVKQ ECCCCCCCEEEEHHH | 62.49 | 21906983 | |
110 | Ubiquitination | NADSEDPKYIINVKQ ECCCCCCCEEEEHHH | 62.49 | 21890473 | |
111 | Ubiquitination | ADSEDPKYIINVKQF CCCCCCCEEEEHHHH | 16.66 | - | |
111 | Phosphorylation | ADSEDPKYIINVKQF CCCCCCCEEEEHHHH | 16.66 | 28152594 | |
116 | Ubiquitination | PKYIINVKQFAKFVV CCEEEEHHHHHHHHE | 34.90 | 21890473 | |
116 | Ubiquitination | PKYIINVKQFAKFVV CCEEEEHHHHHHHHE | 34.90 | 21890473 | |
116 | Acetylation | PKYIINVKQFAKFVV CCEEEEHHHHHHHHE | 34.90 | 19608861 | |
116 | Succinylation | PKYIINVKQFAKFVV CCEEEEHHHHHHHHE | 34.90 | 23954790 | |
116 | Ubiquitination | PKYIINVKQFAKFVV CCEEEEHHHHHHHHE | 34.90 | 21890473 | |
116 | Ubiquitination | PKYIINVKQFAKFVV CCEEEEHHHHHHHHE | 34.90 | 21890473 | |
120 | Ubiquitination | INVKQFAKFVVDLSD EEHHHHHHHHEECCC | 39.72 | 21906983 | |
130 | Ubiquitination | VDLSDQVAPTDIEEG EECCCCCCCCCHHHC | 8.81 | - | |
131 | Ubiquitination | DLSDQVAPTDIEEGM ECCCCCCCCCHHHCC | 31.57 | - | |
132 | Phosphorylation | LSDQVAPTDIEEGMR CCCCCCCCCHHHCCE | 39.61 | - | |
138 | Sulfoxidation | PTDIEEGMRVGVDRN CCCHHHCCEECCCCC | 3.38 | 21406390 | |
146 | Ubiquitination | RVGVDRNKYQIHIPL EECCCCCCEEEECCC | 39.15 | 21890473 | |
146 | Ubiquitination | RVGVDRNKYQIHIPL EECCCCCCEEEECCC | 39.15 | 21890473 | |
146 | Ubiquitination | RVGVDRNKYQIHIPL EECCCCCCEEEECCC | 39.15 | 21906983 | |
146 | Ubiquitination | RVGVDRNKYQIHIPL EECCCCCCEEEECCC | 39.15 | 21890473 | |
147 | Phosphorylation | VGVDRNKYQIHIPLP ECCCCCCEEEECCCC | 19.09 | 27642862 | |
156 | Ubiquitination | IHIPLPPKIDPTVTM EECCCCCCCCCCEEE | 58.77 | - | |
160 | Phosphorylation | LPPKIDPTVTMMQVE CCCCCCCCEEEEEEE | 25.51 | 20860994 | |
163 | Sulfoxidation | KIDPTVTMMQVEEKP CCCCCEEEEEEEECC | 1.21 | 28465586 | |
164 | Sulfoxidation | IDPTVTMMQVEEKPD CCCCEEEEEEEECCC | 2.70 | 28465586 | |
169 | Acetylation | TMMQVEEKPDVTYSD EEEEEEECCCCCHHH | 32.77 | 26051181 | |
169 | Ubiquitination | TMMQVEEKPDVTYSD EEEEEEECCCCCHHH | 32.77 | - | |
173 | Phosphorylation | VEEKPDVTYSDVGGC EEECCCCCHHHCCCH | 25.37 | 29978859 | |
174 | Phosphorylation | EEKPDVTYSDVGGCK EECCCCCHHHCCCHH | 11.61 | 29978859 | |
175 | Phosphorylation | EKPDVTYSDVGGCKE ECCCCCHHHCCCHHH | 19.22 | 29978859 | |
179 | Ubiquitination | VTYSDVGGCKEQIEK CCHHHCCCHHHHHHH | 21.12 | - | |
181 | Ubiquitination | YSDVGGCKEQIEKLR HHHCCCHHHHHHHHH | 56.80 | - | |
186 | Ubiquitination | GCKEQIEKLREVVET CHHHHHHHHHHHHHC | 55.24 | - | |
193 | Phosphorylation | KLREVVETPLLHPER HHHHHHHCCCCCHHH | 13.97 | - | |
203 | Ubiquitination | LHPERFVNLGIEPPK CCHHHHHCCCCCCCC | 29.82 | - | |
210 | Ubiquitination | NLGIEPPKGVLLFGP CCCCCCCCEEEEECC | 72.82 | 21890473 | |
210 | Ubiquitination | NLGIEPPKGVLLFGP CCCCCCCCEEEEECC | 72.82 | 21890473 | |
210 | Ubiquitination | NLGIEPPKGVLLFGP CCCCCCCCEEEEECC | 72.82 | 21906983 | |
210 | Ubiquitination | NLGIEPPKGVLLFGP CCCCCCCCEEEEECC | 72.82 | 21890473 | |
219 | Ubiquitination | VLLFGPPGTGKTLCA EEEECCCCCCHHHHH | 50.67 | - | |
222 | Acetylation | FGPPGTGKTLCARAV ECCCCCCHHHHHHHH | 37.86 | 25953088 | |
222 | Ubiquitination | FGPPGTGKTLCARAV ECCCCCCHHHHHHHH | 37.86 | 20639865 | |
236 | Glutathionylation | VANRTDACFIRVIGS HHCCCCCEEEEHHCH | 3.03 | 22555962 | |
243 | Phosphorylation | CFIRVIGSELVQKYV EEEEHHCHHHHHHHH | 19.34 | - | |
248 | Ubiquitination | IGSELVQKYVGEGAR HCHHHHHHHHHHHHH | 34.13 | 21890473 | |
248 | Ubiquitination | IGSELVQKYVGEGAR HCHHHHHHHHHHHHH | 34.13 | 21890473 | |
248 | Acetylation | IGSELVQKYVGEGAR HCHHHHHHHHHHHHH | 34.13 | 26051181 | |
248 | Ubiquitination | IGSELVQKYVGEGAR HCHHHHHHHHHHHHH | 34.13 | 21906983 | |
248 | Ubiquitination | IGSELVQKYVGEGAR HCHHHHHHHHHHHHH | 34.13 | 21890473 | |
249 | Phosphorylation | GSELVQKYVGEGARM CHHHHHHHHHHHHHH | 9.15 | 21406692 | |
263 | Sulfoxidation | MVRELFEMARTKKAC HHHHHHHHHHHCCEE | 2.10 | 21406390 | |
265 | Ubiquitination | RELFEMARTKKACLI HHHHHHHHHCCEEEE | 45.85 | - | |
267 | Ubiquitination | LFEMARTKKACLIFF HHHHHHHCCEEEEEE | 32.59 | - | |
268 | Ubiquitination | FEMARTKKACLIFFD HHHHHHCCEEEEEEC | 43.66 | 21890473 | |
270 | Ubiquitination | MARTKKACLIFFDEI HHHHCCEEEEEECCC | 4.04 | - | |
278 | Ubiquitination | LIFFDEIDAIGGARF EEEECCCCCCCCCCC | 30.04 | - | |
281 | Ubiquitination | FDEIDAIGGARFDDG ECCCCCCCCCCCCCC | 25.98 | - | |
285 | Acetylation | DAIGGARFDDGAGGD CCCCCCCCCCCCCCC | 11.28 | - | |
285 | Ubiquitination | DAIGGARFDDGAGGD CCCCCCCCCCCCCCC | 11.28 | - | |
316 | Sumoylation | FDPRGNIKVLMATNR CCCCCCEEEEEECCC | 33.06 | - | |
316 | Ubiquitination | FDPRGNIKVLMATNR CCCCCCEEEEEECCC | 33.06 | 21906983 | |
340 | Acetylation | RPGRLDRKIEFSLPD CCCCCCCEEEEECCC | 46.37 | 26051181 | |
340 | Ubiquitination | RPGRLDRKIEFSLPD CCCCCCCEEEEECCC | 46.37 | 21906983 | |
356 | Ubiquitination | EGRTHIFKIHARSMS CCCEEEEEEEECCCC | 32.74 | 21890473 | |
356 | Ubiquitination | EGRTHIFKIHARSMS CCCEEEEEEEECCCC | 32.74 | 21890473 | |
356 | Acetylation | EGRTHIFKIHARSMS CCCEEEEEEEECCCC | 32.74 | 25953088 | |
356 | Ubiquitination | EGRTHIFKIHARSMS CCCEEEEEEEECCCC | 32.74 | 21906983 | |
356 | Ubiquitination | EGRTHIFKIHARSMS CCCEEEEEEEECCCC | 32.74 | 21890473 | |
361 | Phosphorylation | IFKIHARSMSVERDI EEEEEECCCCCCHHH | 19.05 | 27251275 | |
363 | Phosphorylation | KIHARSMSVERDIRF EEEECCCCCCHHHHH | 23.29 | 24719451 | |
389 | Glutathionylation | GAEIRSVCTEAGMFA CHHHHHHHHHHHHHH | 2.76 | 22555962 | |
389 | S-nitrosylation | GAEIRSVCTEAGMFA CHHHHHHHHHHHHHH | 2.76 | 2212679 | |
394 | Sulfoxidation | SVCTEAGMFAIRARR HHHHHHHHHHHHHHH | 2.36 | 21406390 | |
402 | Ubiquitination | FAIRARRKIATEKDF HHHHHHHHCCCHHHH | 31.01 | 21906983 | |
405 | Phosphorylation | RARRKIATEKDFLEA HHHHHCCCHHHHHHH | 47.22 | - | |
407 | Ubiquitination | RRKIATEKDFLEAVN HHHCCCHHHHHHHHH | 49.80 | 21890473 | |
407 | Ubiquitination | RRKIATEKDFLEAVN HHHCCCHHHHHHHHH | 49.80 | 21890473 | |
407 | Acetylation | RRKIATEKDFLEAVN HHHCCCHHHHHHHHH | 49.80 | 25953088 | |
407 | Ubiquitination | RRKIATEKDFLEAVN HHHCCCHHHHHHHHH | 49.80 | 21906983 | |
407 | Ubiquitination | RRKIATEKDFLEAVN HHHCCCHHHHHHHHH | 49.80 | 21890473 | |
415 | Ubiquitination | DFLEAVNKVIKSYAK HHHHHHHHHHHHHHC | 38.44 | 21890473 | |
415 | Ubiquitination | DFLEAVNKVIKSYAK HHHHHHHHHHHHHHC | 38.44 | 21890473 | |
415 | Acetylation | DFLEAVNKVIKSYAK HHHHHHHHHHHHHHC | 38.44 | 25953088 | |
415 | Ubiquitination | DFLEAVNKVIKSYAK HHHHHHHHHHHHHHC | 38.44 | 21906983 | |
415 | Ubiquitination | DFLEAVNKVIKSYAK HHHHHHHHHHHHHHC | 38.44 | 21890473 | |
418 | Ubiquitination | EAVNKVIKSYAKFSA HHHHHHHHHHHCCCC | 40.16 | - | |
422 | Ubiquitination | KVIKSYAKFSATPRY HHHHHHHCCCCCCCC | 31.45 | 21890473 | |
422 | Ubiquitination | KVIKSYAKFSATPRY HHHHHHHCCCCCCCC | 31.45 | 21890473 | |
422 | Acetylation | KVIKSYAKFSATPRY HHHHHHHCCCCCCCC | 31.45 | 19608861 | |
422 | Ubiquitination | KVIKSYAKFSATPRY HHHHHHHCCCCCCCC | 31.45 | 21906983 | |
422 | Ubiquitination | KVIKSYAKFSATPRY HHHHHHHCCCCCCCC | 31.45 | 21890473 | |
424 | Phosphorylation | IKSYAKFSATPRYMT HHHHHCCCCCCCCCC | 30.44 | 28851738 | |
426 | Phosphorylation | SYAKFSATPRYMTYN HHHCCCCCCCCCCCC | 13.70 | - | |
428 | Methylation | AKFSATPRYMTYN-- HCCCCCCCCCCCC-- | 29.51 | 115492839 | |
429 | Phosphorylation | KFSATPRYMTYN--- CCCCCCCCCCCC--- | 8.60 | 28851738 | |
431 | Phosphorylation | SATPRYMTYN----- CCCCCCCCCC----- | 15.81 | 28851738 | |
432 | Phosphorylation | ATPRYMTYN------ CCCCCCCCC------ | 11.44 | 28851738 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PRS7_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PRS7_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PRS7_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-116 AND LYS-422, AND MASSSPECTROMETRY. |